Zanubrutinib
BGB-3111-309
Phase 3 small_molecule active
Quick answer
Zanubrutinib for Primary Membranous Nephropathy is a Phase 3 program (small_molecule) at BeOne Medicines with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BeOne Medicines
- Indication
- Primary Membranous Nephropathy
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active